IONZ

Defiance Daily Target 2x Short IONQ ETF

$5.20
+0.00%
Market closed. Last update: 10:56 PM ET

📎 Investment Objective

The Defiance Daily Target 2x Short IONQ ETF (IONZ) seeks to provide daily investment results that correspond to twice the inverse (-2x) of the daily performance of the common stock of IonQ, Inc., a quantum computing company.

Overview

ETF tracking Defiance Daily Target 2x Short IONQ ETF

Category Inverse
Issuer Other
Inception Date 2025-06-24
Market Cap $75.7M
Average Volume N/A
Dividend Yield N/A
52-Week Range $2.30 - $22.95
VWAP $5.42

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The Defiance Daily Target 2x Short IONQ ETF (IONZ) seeks to provide daily investment results that correspond to twice the inverse (-2x) of the daily performance of the common stock of IonQ, Inc., a quantum computing company.

🎯 Investment Strategy

The fund uses a combination of financial instruments, such as futures contracts and swaps, to achieve its daily -2x target exposure to the underlying stock. It does not seek to achieve its stated investment objective over periods longer than a single day.

✨ Key Features

  • Inverse 2x exposure to the daily performance of IonQ, Inc. stock
  • Designed for short-term, tactical trading rather than long-term investment
  • Resets exposure daily, which can lead to compounding effects over longer periods
  • Relatively low assets under management and expense ratio of 0.00%

⚠️ Primary Risks

  • Significant daily volatility and potential for large losses, especially over periods longer than one day
  • Risk of compounding losses due to the daily resetting of exposure
  • Lack of long-term performance history to evaluate
  • Liquidity risk due to low assets under management

👤 Best For

This ETF is intended for experienced, risk-tolerant traders who seek short-term, speculative exposure to the inverse performance of IonQ, Inc. stock. It is not suitable for long-term, buy-and-hold investors or those with a low risk tolerance.